Management of malignant bowel obstruction

European Journal of Cancer

Volumn 44, Issue 8, 2008, Pages 1105-1115

  Ripamonti, Carla Ida ^a,b   Easson, Alexandra M ^c   Gerdes, Hans ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF TORONTO   (Canada)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Advanced end stage cancer patients; Malignant bowel obstruction; Nasogastric suction; Palliative medical treatment; Stents; Surgery; Symptom control

Indexed keywords

ANALGESIC AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; BUPRENORPHINE; BUTYROPHENONE DERIVATIVE; CHLORPROMAZINE; CYCLIZINE; DEXAMETHASONE; DIAMORPHINE; DIATRIZOATE; FENTANYL; GLYCOPYRRONIUM BROMIDE; HALOPERIDOL; HYDROMORPHONE; LEVOMEPROMAZINE; METAL; METHADONE; METOCLOPRAMIDE; MORPHINE; OCTREOTIDE; OPIATE; OXYCODONE; PHENOTHIAZINE; PROCHLORPERAZINE; SCOPOLAMINE BROMIDE; SCOPOLAMINE BUTYL BROMIDE; SOMATOSTATIN DERIVATIVE; STEROID; STOMACH SECRETION INHIBITOR; UNINDEXED DRUG;

ABDOMINAL DRAINAGE; ANALGESIA; ARTICLE; ASCITES; CANCER PATIENT; CANCER SURGERY; CARCINOMATOSIS; COMPUTER ASSISTED TOMOGRAPHY; DECISION MAKING; ENDOSCOPY; GASTROSTOMY; HUMAN; INTESTINE OBSTRUCTION; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PATIENT SELECTION; PERFORMANCE; PHYSICIAN; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADIOLOGY; SKIN IRRITATION; STENT; STOMACH OBSTRUCTION; SYMPTOM; TREATMENT PLANNING; VOMITING; WORLD HEALTH ORGANIZATION;

EID: 43649085912     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.02.028     Document Type: Article

References (83)

1. T. Anthony T. Baron S. Mercadante Report of the clinical protocol committee: development of randomized trials for malignant bowel obstruction J Pain Symptom Manage 34 2007 S49 S59
2. C. Ripamonti E. Bruera Palliative management of malignant bowel obstruction Int J Gynecol Cancer 12 2002 135 143
3. R.S. Krouse The international conference on malignant bowel obstruction: a meeting of the minds to advance palliative care research J Pain Symptom Manage 34 2007 S1 S6
4. H. Legendre F. Vanhuyse F.X. Caroli-Bosc Survival and quality of life after palliative surgery for neoplastic gastrointestinal obstruction Eur J Surg Oncol 27 2001 364 367
5. S. Suri S. Gupta P.J. Sudhakar Comparative evaluation of plain films, ultrasound and CT in the diagnosis of intestinal obstruction Acta Radiol 40 1999 422 428
6. W.M. Thompson R.K. Kilani B.B. Smith Accuracy of abdominal radiography in acute small-bowel obstruction: does reviewer experience matter? AJR Am J Roentgenol 188 2007 W233 W238
7. E. De Bree W. Koops R. Kroger Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement J Surg Oncol 86 2004 64 73
8. P. Jacquet J.S. Jelinek M.A. Steves Evaluation of computed tomography in patients with peritoneal carcinomatosis Cancer 72 1993 1631 1636
9. P.G. Taourel J.M. Fabre J.A. Pradel Value of CT in the diagnosis and management of patients with suspected acute small-bowel obstruction AJR Am J Roentgenol 165 1995 1187 1192
10. D.P. Beall B.J. Fortman B.C. Lawler Imaging bowel obstruction: a comparison between fast magnetic resonance imaging and helical computed tomography Clin Radiol 57 2002 719 724
11. A.M. Easson K.F. Lee K. Brasel Clinical research for surgeons in palliative care: challenges and opportunities J Am Coll Surg 196 2003 141 151
12. L.E. McCahill R.S. Krouse D.Z. Chu Decision making in palliative surgery J Am Coll Surg 195 2002 411 422
13. D. Bryan R. Radbod J. Berek An analysis of surgical versus chemotherapeutic intervention for the management of intestinal obstruction in advanced ovarian cancer Int J Gynecol Cancer 16 2004 125 134
14. H. Higashi H. Shida K. Ban Factors affecting successful palliative surgery for malignant bowel obstruction due to peritoneal dissemination from colorectal cancer Jpn J Clin Oncol 33 2003 357 359
15. D. Spiegel Effects of psychotherapy on cancer survival Nat Rev Cancer 2 2002 383 389
16. C. Ripamonti R. Twycross M. Baines Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer Support Care Cancer 9 2001 223 233
17. L.K. Helyer C.H. Law M. Butler Surgery as a bridge to palliative chemotherapy in patients with malignant bowel obstruction from colorectal cancer Ann Surg Oncol 14 2007 1264 1271
18. S.M. Abbas A.E. Merrie Resection of peritoneal metastases causing malignant small bowel obstruction World J Surg Oncol 5 2007 122
19. B. Hofmann L.L. Heheim J.A. Soreide Ethics of palliative surgery in patients with cancer Br J Surg 92 2005 809
20. M.H. Tattersall P.N. Butow J.M. Clayton Insights from cancer patient communication research Hematology Oncology Clinics of North America 16 2002 731 743
21. B. Hofmann L.L. Haheim J.A. Soreide Ethics of palliative surgery in patients with cancer Br J Surg 92 2005 802 809
22. M.H. Tattersall P.N. Butow J.M. Clayton Insights from cancer patient communication research Hematol Oncol Clin North Am 16 2002 731 743
23. A.S. Lowe C.G. Beckett S. Jowett Self-expandable metal stent placement for the palliation of malignant gastroduodenal obstruction: experience in a large, single, UK centre Clin Radiol 62 2007 738 744
24. J.J. Telford D.L. Carr-Locke T.H. Baron Palliation of patients with malignant gastric outlet obstruction with the enteral Wallstent: outcomes from a multicenter study Gastrointest Endosc 60 2004 916 920
25. A. Dormann S. Meisner N. Verin Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness Endoscopy 36 2004 543 550
26. T. Nassif F. Prat B. Meduri Endoscopic palliation of malignant gastric outlet obstruction using self-expandable metallic stents: results of a multicenter study Endoscopy 35 2003 483 489
27. A.P. Holt M. Patel M.M. Ahmed Palliation of patients with malignant gastroduodenal obstruction with self-expanding metallic stents: the treatment of choice? Gastrointest Endosc 60 2004 1010 1017
28. J. Espinel O. Sanz S. Vivas Malignant gastrointestinal obstruction: endoscopic stenting versus surgical palliation Surg Endosc 20 2006 1083 1087
29. K.D. Lillemoe J.L. Cameron J.M. Hardacre Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial Ann Surg 230 1999 322 328 discussion 328-30
30. S.M. Jeurnink E.W. Steyerberg G.V. Hof Gastrojejunostomy versus stent placement in patients with malignant gastric outlet obstruction: a comparison in 95 patients J Surg Oncol 2007
31. Y.T. Wong D.M. Brams L. Munson Gastric outlet obstruction secondary to pancreatic cancer: surgical vs endoscopic palliation Surg Endosc 16 2002 310 312
32. S. Mehta A. Hindmarsh E. Cheong Prospective randomized trial of laparoscopic gastrojejunostomy versus duodenal stenting for malignant gastric outflow obstruction Surg Endosc 20 2006 239 242
33. Schmidt C, Gerdes H, Hawkins W, et al. Palliation for malignant gastric outlet obstruction: A prospective quality of life study. Manuscript in Preparation.
34. F. Camunez A. Echenagusia G. Simo Malignant colorectal obstruction treated by means of self-expanding metallic stents: Effectiveness before surgery and in palliation Radiology 216 2000 492 497
35. W.L. Law K.W. Chu J.W. Ho Self-expanding metallic stent in the treatment of colonic obstruction caused by advanced malignancies Dis Colon Rectum 43 2000 1522 1527
36. A. Mainar M.A. De Gregorio E. Tejero Acute colorectal obstruction: Treatment with self-expandable metallic stents before scheduled surgery—Results of a multicenter study Radiology 210 1999 65 69
37. C.L. Nash A.J. Markowitz M. Schattner Colorectal stents for the management of malignant large bowel obstruction Gastrointest Endo 55 2002 AB216
38. B. Pothuri A. Guiguis H. Gerdes The use of colorectal stents for palliation of large bowel obstruction due to recurrent gynecologic cancer Gynecol Oncol 95 2004 513 517
39. U.P. Khot A. Wenk Lang K. Murali Systematic review of the efficacy and safety of colorectal stents Br J Surg 89 2002 1096 1102
40. S. Sebastian S. Johnston T. Geoghegan Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction Am J Gastro 99 2004 2051 2057
41. E. Campagnutta R. Cannizzaro A. Gallo A. Zarrelli M. Valentini M. De Cicco Palliative Treatment of Upper Intestinal Obstruction by Gynecological Malignancy: The Usefulness of Percutaneous Endoscopic Gastrostomy Gynecologic Oncology 62 1996 103 105
42. B. Pothuri M. Montemarano M. Gerardi M. Shike L. Ben-Porat P. Sabbatinin Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma Gynecologic Oncology 96 2005 330 334
43. World Health Organization Cancer Pain Relief second ed. 1996 WHO Geneve
44. Mercadante S. What is the opioid of choice? Progress Palliat Care, in press.
45. S. Mercadante M. Sapio R. Serretta Treatment of pain in chronic bowel subobstruction with self-administration of methadone Support Care Cancer 5 1997 327 329
46. G.W. Hanks F. De Conno N. Cherny Expert Working Group of the Research Network of the European Association for Palliative Care. Morphine and alternative opioids in cancer pain: the EAPC recommendations British Journal of Cancer 84/5 2001 587 593
47. S.L. Anderson S.T. Shreve Continuous subcutaneous infusion of opiates at the end-life Ann Pharmacother 38 2004 1015 1023
48. C. Ripamonti E. Bruera Current status of patient-controlled analgesia in cancer patients Oncology 11 1997 373 384
49. S. Grond L. Radbruch K.A. Lehmann Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl Clin Pharmacokin 38 2000 59 89
50. R.B.R. Muijsers A.J. Wagstaff Transdermal fentanyl. An updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control Drugs 61 2001 2289 2307
51. K. Böhme Buprenorphine in a transdermal therapeutic system – a new option Clin Rheumatol Suppl 1 2002 S13 S16
52. R.L. Fainsinger K. Spachynski J. Hanson Symptom control in terminally ill patients with malignant bowel obstruction J Pain Symptom Manage 9 1994 12 18
53. V. Ventafridda C. Ripamonti A. Caraceni The management of inoperable gastrointestinal obstruction in terminal cancer patients Tumouri 76 1990 389 393
54. S. Mercadante Pain in inoperable bowel obstruction Pain Digest 5 1995 9 13
55. F. De Conno A. Caraceni E. Zecca E. Spoldi V. Ventafridda Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction J Pain Sympt Manage 6 1991 484 486
56. C. Ripamonti S. Mercadante L. Groff E. Zecca F. De Conno A. Casuccio Role of octreotide, scopolamine butylbromide and hydration in symptom control of patients with inoperable bowel obstruction having a nasogastric tube. A prospective, randomized clinical trial J Pain Symptom Manage 19 2000 23 34
57. S. Mercadante C. Ripamonti A. Casuccio E. Zecca L. Groff Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction Supportive Care in Cancer 8 2000 188 191
58. M. Baines D.J. Oliver R.L. Carter Medical management of intestinal obstruction in patients with advanced malignant disease: a clinical and pathological study Lancet 2 1985 990 993
59. W.H. Isbister P. Elder L. Symons Non-operative management of malignant intestinal obstruction J R Coll Surg Edinb 35 1990 369 372
60. S. Mercadante S. Maddaloni Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patients J Pain Symptom Manage 7 8 1992 496 498
61. S. Mercadante E. Spoldi A. Caraceni S. Maddaloni M.T. Simonetti Octreotide in relieving gastrointestinal symptoms due to bowel obstruction Palliative Medicine 7 1993 295 299
62. D. Khoo J. Riley J. Waxman Control of emesis in bowel obstruction in terminally ill patients The Lancet 339 1992 375 376
63. J. Riley M.T. Fallon Octreotide in terminal malignant obstruction of the gastrointestinal tract European J Palliative Care 1/1 1994 20 22
64. F. Stiefel R. Morant Vapreotide, a new somatostatin analogue in the palliative management of obstructive ileus in advanced cancer Supportive Care Cancer 1 1993 57 58
65. G. Mangili M. Franchi A. Mariani F. Zanaboni E. Rabaiotti L. Frigerio Octreotide in the management of bowel obstruction in terminal ovarian cancer Gynecologic Oncology 61 1996 345 348
66. M.P. Davis A. Furste Glycopyrrolate: a useful drug in the Palliation of Mechanical Bowel Obstruction J Pain Symptom Manage 18 1999 153 154
67. C. Ripamonti C. Panzeri L. Groff G. Galeazzi R. Boffi The role of somatostatin and octreotide in bowel obstruction: pre-clinical and clinical results Tumouri 87 2001 1 9
68. G.J. Anthone J.A. Bastidas M.S. Orlandle C.J. Yeo Direct proabsorptive effect of octreotide on ionic transport in the small intestine Surgery 108 1990 1136 1142
69. M.D. Basson L.P. Fielding A.J. Bilchik Does vasoactive intestinal polypeptide mediate the pathophysiology of bowel obstruction? Am J Surg 157 1989 109 115
70. R. Neville P. Fielding R.P. Cambria I. Modlin Vascular responsiveness in obstructed gut Dis Colon Rectum 34 1991 229 235
71. P. Nellgard L. Bojo J. Cassuto Importance of vasoactive intestinal peptide and somatostatin for fluid losses in small-bowel obstruction Scand J Gastroenterol 30 1995 464 469
72. S. Mercadante J. Kargar G. Nicolosi Octreotide may prevent definitive intestinal obstruction J Pain Symptom Manage 13 1997 352 355
73. S. Mercadante P. Ferrera P. Villari A. Marrazzo Aggressive pharmacological treatment for reversing malignant bowel obstruction J Pain Symptom Manage 28 2004 412 416
74. K. Steadman A. Franks A woman with malignant bowel obstruction who did not want to die with tubes Lancet 347 1996 944
75. S. Mercadante G. Avola S. Maddaloni Octreotide prevents the pathological alterations of bowel obstruction in cancer patients Support Care Cancer 4 1996 393 394
76. X. Sun X. Li H. Li Management of intestinal obstruction in advanced ovarian cancer: an analysis of 57 cases [in Chinese] Zhonghua Zhong Liu Za Zhi 17 1995 39 42
77. R. Twycross I. Back Nausea and vomiting in advanced cancer European J of Palliative Care 5 2 1998 39 45
78. D.J. Feuer K.E. Broadley Systematic review and meta-analysis of corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancers. Systematic Review Steering Committee Ann Oncol 10 1999 1035 1041
79. L. Cozzaglio Outcome of cancer patients receiving home parenteral nutrition J Parenteral Enteral Nutrition 21 1997 339 342
80. D. Hoda A. Jatoi J. Burnes C. Loprinzi D. Kelly Should patients with advanced, incurable cancers ever be sent home with Total parenteral nutrition? Cancer 103 2005 863 868
81. F.I. Burge Dehydration symptoms of palliative care cancer patients J Pain Symptom Manage 8 1993 454 464
82. R.L. Fainsinger T. MacEachern M.J. Miller The use of hypodermoclysis for rehydration in terminally ill cancer patients J Pain Sympt Manage 9 1994 298 302
83. Ventafridda et al. (2003) Mouth care. In: Doyle D, Hanks GWC, Cherny N, et al., editors. Oxford Textbook of palliative medicine, 3rd ed. Oxford: Oxford University Press; 2005.